SilverCape Lowers Takeover Offer for PetMed to $3/Share Citing Business Decline
PetMed’s board will review the lowered offer.
Already have an account? Sign in.
PetMed’s board will review the lowered offer.
Novartis and Ionis said pelacarsen lowered Lp(a) but failed to cut heart attacks, strokes or deaths in a Phase 3 trial of 8,323 patients.
Canaccord cites tinlarebant as the first drug shown to slow Stargardt lesion growth. The PDUFA date is February 12, 2027.
AMC CEO Adam Aron calls Robinhood’s AMC stock tokens vile and a fake market, demands a halt, and considers an SEC complaint.